COVID-19 advice for the public: Getting vaccinated

Children and adolescents tend to have milder disease compared to adults, so unless they are part of a group at higher risk of severe COVID-19, it is less urgent to vaccinate them than older people, those with chronic health conditions and health workers.   

More evidence is needed on the use of the different COVID-19 vaccines in children to be able to make general recommendations on vaccinating children against COVID-19.

WHO's Strategic Advisory Group of Experts (SAGE) has concluded that the Pfizer/BionTech vaccine is suitable for use by people aged 12 years and above. Children aged between 12 and 15 who are at high risk may be offered this vaccine alongside other priority groups for vaccination. Vaccine trials for children are ongoing and WHO will update its recommendations when the evidence or epidemiological situation warrants a change in policy.

A Phase 3 trial in children aged 12-15 years showed high efficacy and good safety in this age group, leading to an extension of the previous age indication from 16 years onwards down to age 12 onwards.

Evidence suggests that adolescents, particularly older adolescents, are as likely to transmit SARS-CoV-2 as adults. WHO recommends that countries should consider using the vaccine in children aged 12 to 15 only when high vaccine coverage with 2 doses has been achieved in the high priority groups as identified in the WHO Prioritization Roadmap

Children 12-15 years of age with comorbidities that put them at significantly higher risk of serious COVID-19 disease, alongside other high-risk groups, may be offered vaccination. 

➡ 若年層のワクチン接種に関して、大阪府泉大津市の南出市長と河野大臣とのディベートを是非観てみたい。も参考になります。

➡ 河野大臣の「ワクチンデマについて」に対する反論が沸き起こっています。河野大臣を擁護する方々の舌鋒も激しく展開中。折角だから、地上波でディベートすればいいのに。も参考になります。

➡ コロナ問題やワクチン問題を、科学的・体系的に理解したい方は、「科学的事実①:はじめに」から「新型コロナウイルス感染症に関する科学的事実(第三版:2021.5.24)」をお読みください。